483 NDAL Mfg Sep 2021

483 NDAL Mfg Sep 2021

Jolanna Norton FDA, Sidonie Takougang FDA$119.00 - Available Now

FDA investigators audited the NDAL Mfg - Monterey, CA, United States facility and issued inspectional observations (via FDA 483) on 20 Sep 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Sep 2021
  • Location: Monterey, United States
  • FEI: 3011219618
Add To Cart